Citation: | ZHANG Ting, HAN Ai-zhi, LONG Zhang-biao, GE Jian, YANG Ming-zhen. Clinical analysis and nursing measures of cutaneous GVHD after allogeneic haematopoietic stem cell transplantation in 152 patients[J]. Chinese Journal of General Practice, 2021, 19(10): 1789-1792. doi: 10.16766/j.cnki.issn.1674-4152.002168 |
[1] |
中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 529-536.
|
[2] |
PASSWEG J R, BALDOMERO H, BADER P, et al. Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report[J]. Bone Marrow Transplant, 2017, 52(6): 811-817. doi: 10.1038/bmt.2017.34
|
[3] |
SCHOEMANS H M, LEE S J, FERRARA J L, et al. EBMT-NIH-CIBMTR task force position statement on standardized terminology & guidance for graft-versus-host disease assessment[J]. Bone Marrow Transplant, 2018, 53(11): 1401-1415. doi: 10.1038/s41409-018-0204-7
|
[4] |
STRONG R K, OLIVEIRA-RIBEIRO C, DE ABREU F S, et al. Cutaneous Graft-Versus-Host disease: Diagnosis and treatment[J]. Am J Clin Dermatol, 2018, 19(1): 33-50. doi: 10.1007/s40257-017-0306-9
|
[5] |
PENACK O, MARCHETTI M, RUUTU T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: Updated consensus recommendations of the European Society for Blood and Marrow Transplantation[J]. Lancet Haematol, 2020, 7(2): e157-e167. doi: 10.1016/S2352-3026(19)30256-X
|
[6] |
DIGNAN F L, CLARK A, AMROLIA P, et al. Diagnosis and management of acute graft-versus-host disease[J]. Br J Haematol, 2012, 158(1): 30-45. doi: 10.1111/j.1365-2141.2012.09129.x
|
[7] |
沈悌, 赵永强. 血液病诊断及疗效标准[M]. 4版. 北京: 科学出版社, 2018.
|
[8] |
JAGASIA M H, GREINIX H T, ARORA M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: Ⅵ. the 2014 diagnois and staging working group report[J]. Biol Blood Marrow Transplant, 2015, 21(3): 389-401. doi: 10.1016/j.bbmt.2014.12.001
|
[9] |
王佳丽, 韩明哲. 异基因造血干细胞移植后植入功能不良发生机制研究进展[J]. 中华血液学杂志, 2019, 40(9): 792-795.
|
[10] |
SHI C R, HUANG J T, NAMBUDIRI V E. Pediatric cutaneous graft versus host disease: A review[J]. Curr Pediatr Rev, 2017, 13(2): 100-110. http://www.onacademic.com/detail/journal_1000040278208610_02d2.html
|
[11] |
胡宇晴, 张建中. 同时具有硬皮病样和皮肤异色病样皮损的慢性移植物抗宿主病[J]. 临床皮肤科杂志, 2020, 49(2): 95-97. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF202002010.htm
|
[12] |
SANTOS E P, BENNETT C L, CHAKRAVERTY R. Unraveling the mechanisms of cutaneous Graft-Versus-Host disease[J]. Front Immunol, 2018, 9: 963. doi: 10.3389/fimmu.2018.00963
|
[13] |
田伟, 郑雅男, 冯昌银, 等. 急性皮肤型移植物抗宿主病8例临床分析并文献复习[J]. 临床皮肤科杂志, 2015, 44(11): 682-684. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF201511003.htm
|
[14] |
杨欢, 李志涛, 林韧, 等. 造血干细胞移植后硬皮病样慢性移植物抗宿主病的临床表现[J]. 南方医科大学学报, 2016, 36(6): 807-813. doi: 10.3969/j.issn.1673-4254.2016.06.13
|
[15] |
NANDA A, HUSAIN M A A, AL-HERZ W, et al. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic[J]. Pediatr Dermatol, 2018, 35(3): 343-353. doi: 10.1111/pde.13432
|
[16] |
常英军. 我如何选择异基因造血干细胞移植供者[J]. 中华血液学杂志, 2016, 37(8): 643-649. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY200732003.htm
|
[17] |
李蒙娜, 闫言, 王宝玺. 紫草素促进皮肤伤口愈合机制研究进展[J]. 中医药学报, 2018, 46(2): 124-128. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB201802032.htm
|
[18] |
余新翠. 运用微信平台延伸护理服务对类风湿关节炎患者的影响[J]. 中华全科医学, 2017, 15(8): 1444-1446. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201708051.htm
|